Joseph Jimenez
Jimenez co-founded Aditum, an investment firm focused on developing biotechnology assets, since 2019. Previously, he was CEO of Novartis Pharmaceuticals from 2010 until 2018, and served as CEO of Europe at H.J. Heinz Company. He currently serves on the boards of the General Motors Company and The Proctor & Gamble Company.
- March 2021
Added to: Graphite Bio - S. San Francisco, CA
Graphite Bio is a next-generation gene editing company focused on therapies that harness targeted DNA integration to treat or cure serious diseases. The company is leveraging its targeted DNA platform to advance a portfolio of transformative treatments with potential for saving and dramatically improving patients' lives.